Jin Medical International Ltd. (ZJYL) Balance Sheet
ZJYL balance sheet, FY2025
September 30, 2025 · U.S. dollars$53.4M assets = $23.8M liabilities + $29.6M equity
Both columns are drawn to the same scale: what ZJYL owns equals what it owes plus shareholders’ equity. Hover a block for its value.
ZJYL financial health
Descriptive bands, not a rating. Fiscal FY2025.
ZJYL balance sheet trends, FY2018–FY2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $18.7MFY2018 | $53.4MFY2025 | +16.2%/yr | |
| Total liabilities | $9.7MFY2018 | $23.8MFY2025 | +13.7%/yr | |
| Shareholders’ equity | $9.0MFY2018 | $29.6MFY2025 | +18.6%/yr | |
| Cash & short-term investments | $2.5MFY2018 | $29.6MFY2025 | +42.7%/yr | |
| Total debt | $712,534FY2018 | $18.9MFY2025 | +59.7%/yr | |
| Net cash (debt) | $1.7MFY2018 | $10.7MFY2025 | +$9.0M | |
| Working capital | $5.9MFY2018 | $20.3MFY2025 | +$14.4M | |
| Book value per share | $0.45FY2018 | $0.54FY2020 | +9.5%/yr | |
| Current ratio | 1.61FY2018 | 1.86FY2025 | +0.24 | |
| Debt / equity | 0.08FY2018 | 0.64FY2025 | +0.56 | |
| Shares outstanding | 20.0MFY2018 | 20.0MFY2020 | 0.0%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
ZJYL assets
ZJYL liabilities and equity
ZJYL debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
ZJYL balance sheet
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & short-term investments | $29.6M | $26.8M | $16.7M | $7.1M | $5.7M | $2.8M | $3.3M | $2.5M |
| Cash & equivalents | $7.5M | $8.1M | $6.9M | $4.8M | $3.7M | $1.7M | $1.9M | $853,304 |
| Short-term investments | $22.2M | $18.6M | $9.8M | $2.3M | $2.1M | $1.2M | $1.4M | $1.6M |
| Receivables | $6.8M | $8.8M | $4.2M | $4.3M | $6.0M | $7.9M | $8.6M | $6.3M |
| Inventory | $4.9M | $7.1M | $5.1M | $6.9M | $7.0M | $7.3M | $5.7M | $6.1M |
| Other current assets | $2.8M | $165,488 | $5.1M | $701,396 | $672,187 | $203,224 | $0 | $748,857 |
| Total current assets | $44.1M | $42.8M | $31.1M | $18.9M | $19.4M | $18.2M | $17.7M | $15.6M |
| Property, plant & equipment (net) | $8.0M | $1.7M | $1.5M | $1.6M | $2.1M | $2.3M | $2.4M | $2.7M |
| Goodwill & intangible assets | $1.1M | $1.1M | $154,364 | $163,213 | $185,101 | $180,891 | $177,293 | $189,345 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $141,801 | $121,322 | $152,475 | $245,212 | $182,714 | $171,901 | $102,695 | $140,159 |
| Total assets | $53.4M | $45.8M | $32.9M | $20.9M | $21.9M | $20.8M | $20.4M | $18.7M |
| Liabilities | ||||||||
| Accounts payable | $3.3M | $3.0M | $3.4M | $4.1M | $5.4M | $5.4M | $4.8M | $7.7M |
| Short-term debt | $18.9M | $11.5M | — | — | — | $2.6M | $2.9M | $712,534 |
| Deferred revenue | $611,233 | $797,077 | — | $830,305 | $1.7M | $975,650 | $1.0M | — |
| Total current liabilities | $23.8M | $17.2M | $8.9M | $5.7M | $7.9M | $10.0M | $9.7M | $9.7M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $72,645 | $281,329 | $0 | — | — | — | — | — |
| Other long-term liabilities | $0 | $96,175 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total liabilities | $23.8M | $17.2M | $8.9M | $5.7M | $7.9M | $10.0M | $9.7M | $9.7M |
| Shareholders' equity | ||||||||
| Common stock & paid-in capital | $7,827 | $7,827 | — | $6,750 | $6,750 | $6,750 | $20,000 | $20,000 |
| Retained earnings (deficit) | $20.9M | $20.0M | $16.9M | $14.4M | $11.9M | $9.6M | $8.5M | $4.9M |
| Accumulated other comprehensive income | $1.9M | $2.0M | — | $740,288 | $2.1M | $1.1M | $43,195 | $461,437 |
| Minority interest | −$66,255 | −$262,724 | $0 | — | — | — | — | — |
| Total shareholders' equity | $29.6M | $28.8M | $24.0M | $15.2M | $14.0M | $10.8M | $10.7M | $9.0M |
| Key figures | ||||||||
| Total debt | $18.9M | $11.6M | — | — | — | $2.6M | $2.9M | $712,534 |
| Net cash (debt) | $10.7M | $15.2M | — | — | — | $192,178 | $471,031 | $1.7M |
| Working capital | $20.3M | $25.7M | $22.2M | $13.2M | $11.5M | $8.1M | $8.0M | $5.9M |
| Tangible book value | $28.5M | $27.7M | $23.8M | $15.1M | $13.8M | $10.6M | $10.5M | $8.8M |
| Book value per share | — | — | — | — | — | $0.54 | $0.54 | $0.45 |
| Shares outstanding | — | — | — | — | — | 20.0M | 20.0M | 20.0M |
| Current ratio | 1.86 | 2.50 | 3.49 | 3.31 | 2.47 | 1.81 | 1.83 | 1.61 |
| Quick ratio | 1.53 | 2.07 | 2.35 | 1.98 | 1.49 | 1.07 | 1.24 | 0.91 |
| Debt / equity | 0.64 | 0.40 | — | — | — | 0.25 | 0.27 | 0.08 |
| Equity / assets | 55.5% | 62.9% | 72.9% | 72.8% | 64.1% | 51.9% | 52.6% | 48.2% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $30.1M | $30.1M | $29.6M | $29.6M | $31.0M | $31.0M | $31.0M | $26.8M | $26.8M | $26.0M | $26.0M | $16.7M |
| Cash & equivalents | $9.1M | $9.1M | $7.5M | $7.5M | $11.1M | $11.1M | $11.1M | $8.1M | $8.1M | $8.9M | $8.9M | $6.9M |
| Short-term investments | $21.0M | $21.0M | $22.2M | $22.2M | $19.8M | $19.8M | $19.8M | $18.6M | $18.6M | $17.1M | $17.1M | $9.8M |
| Receivables | $6.6M | $5.5M | $6.8M | $5.9M | $5.6M | $5.6M | $5.6M | $8.8M | $8.5M | $5.5M | $5.4M | $8.5M |
| Inventory | $7.1M | $5.8M | $4.9M | $4.9M | $6.1M | $6.1M | $6.1M | $7.1M | $7.1M | $6.4M | $6.4M | $5.9M |
| Other current assets | $576,200 | $3.2M | $2.8M | $3.7M | $1.1M | $1.1M | $1.1M | $165,488 | $482,796 | $280,652 | $440,647 | $60,000 |
| Total current assets | $44.4M | $44.6M | $44.1M | $44.1M | $43.8M | $43.8M | $43.8M | $42.8M | $42.8M | $38.2M | $38.2M | $31.1M |
| Property, plant & equipment (net) | $9.9M | $9.9M | $8.0M | $8.0M | $3.5M | $3.5M | $3.5M | $1.7M | $1.7M | $1.7M | $1.7M | $1.5M |
| Goodwill & intangible assets | $0 | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $154,364 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $1.5M | $256,759 | $141,801 | $141,801 | $134,447 | $134,447 | $134,447 | $121,322 | $121,322 | $130,441 | $130,441 | $152,475 |
| Total assets | $55.8M | $55.8M | $53.4M | $53.4M | $48.5M | $48.5M | $48.5M | $45.8M | $45.8M | $41.2M | $41.2M | $32.9M |
| Liabilities | ||||||||||||
| Accounts payable | $2.6M | $2.6M | $3.3M | $3.3M | $3.1M | $3.1M | $3.1M | $3.0M | $3.0M | $3.1M | $3.1M | $3.4M |
| Short-term debt | $17.7M | — | $18.9M | — | $15.9M | $15.9M | $15.9M | $11.5M | $11.5M | $9.8M | $9.8M | $4.1M |
| Deferred revenue | $635,105 | — | $611,233 | — | — | $460,440 | $797,077 | $797,077 | $678,509 | $678,509 | — | $829,219 |
| Total current liabilities | $22.8M | $22.8M | $23.8M | $23.8M | $20.7M | $20.7M | $20.7M | $17.2M | $17.2M | $14.8M | $14.8M | $8.9M |
| Long-term debt | $0 | $2.9M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | — | $57,433 | — | $72,645 | — | $189,515 | — | $281,329 | — | $267,988 | — | $0 |
| Other long-term liabilities | $2.9M | $0 | $0 | $0 | $30,095 | $30,095 | $30,095 | $96,175 | $96,175 | $179,691 | $179,691 | $0 |
| Total liabilities | $25.7M | $25.7M | $23.8M | $23.8M | $20.8M | $20.8M | $20.8M | $17.2M | $17.2M | $15.0M | $15.0M | $8.9M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $7,827 | — | $7,827 | — | $7,827 | $7,827 | $7,827 | $7,827 | $7,827 | $7,827 | $7,827 | $7,797 |
| Retained earnings (deficit) | $20.8M | $20.8M | $20.9M | $20.9M | $22.5M | $22.5M | $22.5M | $20.0M | $22.6M | $18.5M | $20.7M | $16.9M |
| Accumulated other comprehensive income | $2.7M | — | $1.9M | — | −$1.4M | −$1.4M | −$1.4M | $2.0M | −$556,209 | $1.0M | −$1.2M | $606,524 |
| Minority interest | — | −$171,090 | — | −$66,255 | — | −$156,229 | — | — | — | — | — | — |
| Total shareholders' equity | $30.3M | $30.3M | $29.6M | $29.6M | $27.9M | $27.9M | $27.9M | $28.8M | $28.8M | $26.2M | $26.2M | $24.0M |
| Key figures | ||||||||||||
| Total debt | $20.6M | $2.9M | $18.9M | — | $15.9M | $15.9M | $15.9M | $11.6M | $11.6M | $9.9M | $9.9M | $4.1M |
| Net cash (debt) | $9.5M | $27.2M | $10.7M | — | $15.0M | $15.0M | $15.0M | $15.2M | $15.2M | $16.0M | $16.0M | $12.6M |
| Working capital | $21.6M | $21.7M | $20.3M | $20.3M | $23.0M | $23.0M | $23.0M | $25.7M | $25.7M | $23.4M | $23.4M | $22.2M |
| Tangible book value | $30.3M | $29.2M | $28.5M | $28.5M | $26.8M | $26.8M | $26.8M | $27.7M | $27.7M | $25.1M | $25.1M | $23.8M |
| Book value per share | — | — | — | — | $0.18 | — | $0.18 | — | $0.18 | — | $0.17 | — |
| Shares outstanding | — | — | — | — | 156.5M | — | 156.5M | — | 156.5M | — | 156.4M | — |
| Current ratio | 1.95 | 1.95 | 1.86 | 1.86 | 2.11 | 2.11 | 2.11 | 2.50 | 2.50 | 2.58 | 2.58 | 3.49 |
| Quick ratio | 1.61 | 1.56 | 1.53 | 1.49 | 1.76 | 1.76 | 1.76 | 2.07 | 2.05 | 2.13 | 2.12 | 2.82 |
| Debt / equity | 0.68 | 0.09 | 0.64 | — | 0.57 | 0.57 | 0.57 | 0.40 | 0.40 | 0.38 | 0.38 | 0.17 |
| Equity / assets | 54.3% | 54.3% | 55.5% | 55.5% | 57.5% | 57.5% | 57.5% | 62.9% | 62.9% | 63.8% | 63.8% | 72.9% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed February 10, 2026); data from EODHD.
ZJYL financial position
At the end of fiscal 2025 (September 30, 2025), Jin Medical International had total assets of $53.4 million (up 16.5% from a year earlier), total liabilities of $23.8 million and shareholders' equity of $29.6 million. It held $29.6 million in cash and short-term investments against $18.9 million of debt, a net cash position of $10.7 million. Its current ratio was 1.86. In the latest quarter (ended June 30, 2026) total assets were $55.8 million and equity $30.3 million.
Related: ZJYL income statement, ZJYL cash flow statement, ZJYL key metrics. See the ZJYL stock overview for the latest quote and news.
ZJYL balance sheet FAQ
What are Jin Medical International's total assets?
Jin Medical International reported total assets of $53.4 million at the end of fiscal 2025 (September 30, 2025), compared with $45.8 million a year earlier.
How much debt does Jin Medical International have?
Jin Medical International had $18.9 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.64.
How much cash does Jin Medical International have?
Jin Medical International held $29.6 million in cash and short-term investments at the end of fiscal 2025; with $18.9 million of debt that is net cash of $10.7 million.
What is Jin Medical International's book value?
Jin Medical International's shareholders' equity (book value) was $29.6 million at the end of fiscal 2025.
What is Jin Medical International's current ratio?
Jin Medical International had current assets of $44.1 million and current liabilities of $23.8 million, a current ratio of 1.86 (it can cover its short-term obligations).
How much goodwill does Jin Medical International have?
Jin Medical International carried $1.1 million of goodwill and intangible assets, 2.1% of total assets, at the end of fiscal 2025.